HtmlToText
sorry, but the browser version you are currently using is not supported by this website. we recommend that you update or download a more recent version. download chrome download firefox download safari download explorer home about who we are our vision our offer our expertise our digital therapeutics for diabetes for oncology other therapeutic areas careers career opportunities our people investors press videos press releases 2018 2017 2016 2015 in the news 2018 2017 2016 brand assets logo products leadership team initial public offering -- en / fr initial public offering -- you have been redirected to the new website. insulia ® the digital therapeutic for people with type 2 diabetes and their care teams go to the website we innovate healthcare solutions by embedding connectivity in therapeutics and medical intelligence in software with excellence and innovation at heart, designs state-of-the-art solutions for chronic and rare diseases to empower patients by embedding intelligence in mobile phones and to simplify care provision by powering health data management. we innovate healthcare solutions by embedding connectivity in therapeutics and medical intelligence in software with excellence and innovation at heart, designs state-of-the-art solutions for chronic and rare diseases to empower patients by embedding intelligence in mobile phones and to simplify care provision by powering health data management. at the forefront of the medical and digital revolutions, is a pioneer in digital therapeutics ok but... what is a digital therapeutic ? we innovate healthcare to improve the patient experience interoperability of devices simplifies data collection, records and sharing coaching messages change behaviors and engage patients symptom tracker monitors quality of life and side effects bidirectional data flow fosters collaboration and coordination we innovate healthcare to support safety and compliant use therapeutic education helps patients take a more active role personalized dosage and guidelines promote compliance and proper use reporting tools and notifications remotely adjust treatment we innovate healthcare to enhance real-life outcomes identification of predictive symptoms prevents acute events configurable dashboards evaluates treatment efficacy, identifies high risk patients and stratifies risk real-world data provides evidence of treatment effectiveness who we are who we are our values leadership team investors -- board of directors was founded in 2001 by three entrepreneurs who believed that innovative medical solutions built with advanced information technologies would improve medical real-life outcomes and thus increase healthcare system efficiency. this would transform patient lives, enhance medical practices and quality of care. every day, teams seek to invent secure, collaborative and patient-centric digital health solutions with a unique combination of web and mobile development excellence, medical and regulatory expertise and certified quality-oriented processes. with more than 600,000 patients managed and more than 50 programs deployed, our track record speaks for itself. 600,000 patients managed 50 programs deployed at , we are all guided by clear and simple values: patient focus: we are committed to changing the daily lives of patients by addressing their unmet needs and by empowering them to manage their chronic conditions. passion for innovation: we design next-generation solutions that combine digital and medical expertise to solve the daily problems of patients and caregivers. respect and integrity: everyday, we take care of the people we touch, our patients, customers, partners and employees. drive for excellence: in everything we do, we behave ethically and we strive to attain the highest level of quality. always working to enhance our processes, we are certified iso 9001 and iso 13485 (regarding quality management systems). we are also compliant with iso 14971 standards (risk management). our design methodologies embed the harmonized iec 62304 and iec 62366 standards (for medical device software). alexandre capet deputy ceo, chief strategy & marketing officer, diabetes division coordinator before joining , alexandre worked 15 years in the pharmaceutical industry. at sanofi, he notably headed the group's strategic planning and m&a; for france, where he strongly contributed to building the diabeo partnership with sanofi, ceritd and . alexandre is a graduate of hec paris and sciences po paris. he holds a master's degree in health economics from paris-dauphine university. pierre leurent chief executive officer and founder pierre has more than 15 years of international experience in software medical devices, disease management and telemedicine solutions in europe and the united states. before founding in 2001, pierre worked with general electric medical systems and with healthcenter internet services, an online cardiology emr solution vendor in san francisco. in addition, pierre is the director of syntec numérique, where he leads the telemedicine workgroup, co-leader of csis-csf’s e-health workgroup and e-health advisor within nouvelle france industrielle’s health steering committee. pierre is a graduate of the ecole centrale paris engineering school. romain marmot deputy ceo, chief operating officer - us, oncology division coordinator, co-founder romain is chief operations officer of and heads the company’s north american operations in cambridge, ma. he has more than 15 years of experience in digital health and software medical devices. he holds an msc from école centrale paris in applied mathematics. dominique laubier chief financial officer dominique has more than 25 years of experience in it and healthcare. before joining , he served as cfo for xiring and then ingenico healthcare. he began his career as financial analyst and then held progressive positions in finance with motorola codex, racal datacom france, cabletron systems. dominique is a graduate of esg business school and holds the french decf degree in accounting. -- matthieu plessis chief financial officer matthieu has 25 years of experience in various finance positions in the pharmaceutical, telecom and it industries. prior to joining , he was cfo of efront, a global financial software vendor. in this position, he successfully supported the group’s rapid growth as well as it’s finance and m&a; operations. previously, he worked for glaxo and sfr-cegetel. he is a graduate of essca management school. geneviève d'orsay md, chief medical officer geneviève has more than 20 years of experience in the life sciences industry. before joining , she was medical affairs director for johnson & johnson medical devices & diagnostics for france & benelux. prior to this position, she worked for altana pharma, chiesi and bioprojet. she holds a doctorate in medicine and a degree in pharmacology and clinical research from university of paris vi as well as a degree in pharmacovigilance from university descartes, paris. olivier berrouiguet chief commercial officer olivier has 20 years of international experience in it and healthcare. prior to joining , olivier was account executive at capgemini, head of sales and business development at sensitive object, general manager at taylor hobson, area manager europe and usa at merck. he began his career in sales at ge sensing france. olivier is a graduate of polytech’lille engineering school and holds an mba from hec paris. -- matthieu plessis chief financial officer matthieu has 25 years of experience in various finance positions in the pharmaceutical, telecom and it industries. prior to joining , he was cfo of efront, a global financial software vendor. in this position he successfully conducted an ipo in europe, as well as the trade public to private sale of the company. previously, he worked for glaxo, sfr-cegetel and cegetel enterprises. he is a graduate of essca management school. etienne vial vice president innovation a
Informations Whois
Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;
Domain Name: VOLUNTIS.COM
Registry Domain ID: 26248211_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.gandi.net
Registrar URL: http://www.gandi.net
Updated Date: 2017-03-06T09:56:24Z
Creation Date: 2000-05-03T07:45:04Z
Registry Expiry Date: 2018-05-03T07:45:04Z
Registrar: Gandi SAS
Registrar IANA ID: 81
Registrar Abuse Contact Email: abuse@support.gandi.net
Registrar Abuse Contact Phone: +33.170377661
Domain Status: ok https://icann.org/epp#ok
Name Server: A.DNS.GANDI.NET
Name Server: B.DNS.GANDI.NET
Name Server: C.DNS.GANDI.NET
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-12-12T23:47:13Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
REGISTRAR Gandi SAS
SERVERS
SERVER com.whois-servers.net
ARGS domain =voluntis.com
PORT 43
TYPE domain
RegrInfo
DOMAIN
NAME voluntis.com
CHANGED 2017-03-06
CREATED 2000-05-03
STATUS
ok https://icann.org/epp#ok
NSERVER
A.DNS.GANDI.NET 173.246.98.1
B.DNS.GANDI.NET 213.167.229.1
C.DNS.GANDI.NET 217.70.179.1
REGISTERED yes
Go to top
voluntis.com rapport :
Visitez le site